Universal Ibogaine (TSXV:IBO) Interest Expense : C$-0.14 Mil (TTM As of Apr. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Universal Ibogaine's interest expense for the three months ended in Apr. 2024 was C$ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2024 was C$-0.14 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Universal Ibogaine's Operating Income for the three months ended in Apr. 2024 was C$ -0.43 Mil. Universal Ibogaine's Interest Expense for the three months ended in Apr. 2024 was C$ -0.04 Mil. Universal Ibogaine did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universal Ibogaine Interest Expense Historical Data

The historical data trend for Universal Ibogaine's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Interest Expense Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Interest Expense

Get a 7-Day Free Trial

-0.07

-0.15

Universal Ibogaine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Interest Expense	Get a 7-Day Free Trial															-0.06	-0.02	-0.04	-0.04	-0.04

Universal Ibogaine Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.14 Mil.

Universal Ibogaine (TSXV:IBO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Universal Ibogaine's Interest Expense for the three months ended in Apr. 2024 was C$-0.04 Mil. Its Operating Income for the three months ended in Apr. 2024 was C$-0.43 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2024 was C$2.64 Mil.

Universal Ibogaine's Interest Coverage for the quarter that ended in Apr. 2024 is calculated as

Universal Ibogaine did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024